Ozaki K, Hatakeyama S, Hamaya T, Okita K, et al. Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma. Int J Urol 2022;29:362-364.
PMID: 34965612